Dapagliflozin
NDC 70710-1381, Dapagliflozin, tablet, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 70710-1381
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211582
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1381 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DAPAGLIFLOZIN10 mg/1
Pharmacologic classes
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70710-1381-3 | 70710138103 | 30 TABLET in 1 BOTTLE (70710-1381-3) |
| 70710-1381-9 | 70710138109 | 90 TABLET in 1 BOTTLE (70710-1381-9) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/17586ec6-0104-4b08-ad87-12a837568d6cNADAC price for package 70710138103
GET /v1/drugs/nadac/70710138103
Use it
Look up 70710-1381 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1381 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70710-1381. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.